PRUCALOPRIDE MEDSURGE prucalopride (as succinate) 1 mg tablet blister pack

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

prucalopride succinate, Quantity: 1.321 mg (Equivalent: prucalopride, Qty 1 mg)

Disponibbli minn:

Medsurge Pharma Pty Ltd

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Excipient Ingredients: titanium dioxide; lactose monohydrate; macrogol 400; colloidal anhydrous silica; magnesium stearate; hypromellose; polysorbate 80; microcrystalline cellulose

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

28 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief.,? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation.,? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Sommarju tal-prodott:

Visual Identification: White to off-white, circular, film coated tablet with 'C' debossed on one side and '11' on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2022-02-04